Bringing the fundamentals into focus…
Back to Taysha Gene Therapies, Inc.
How Taysha Gene Therapies, Inc. stacks up
TSHA · against 413 other Healthcare companies of similar size
Growth
72/ 100
Above the middle of the pack.
Ranked #108 of 414 · scores higher than 73% of peers
Bars: peers in each 10-point band of the growth score39 peers with a growth score of 70–79, including TSHA · Click a bar to see the companies
Why growth scores 72?
Weighted metrics compared with all Healthcare companies.Mainly thanks to its 3-year revenue growth, which is stronger than most Healthcare peers.
- slower revenue growth over the last year: weaker than 93% of peers. Revenue growth: -32.3% vs peer median 6.1%
- Earnings per share growth is not reported, so it is left out of the score.
- faster revenue growth over three years: stronger than 93% of peers. 3-year revenue growth: 57.5% vs peer median 5.8%
Metric by metric
Position: dot = TSHA, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | TSHA | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 419 reported | -32.3% | 5.2% | 7% | 33% | |
| Earnings per share growthHigher is better · 231 reported | Not reported | 8.3% | — | — | 33% |
| 3-year revenue growthHigher is better · 406 reported | 57.5% | 6.0% | 96% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
Ranking by growth score
Top 5 and the companies ranked around TSHA| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 8.9B HKD (≈$1.1B) | 99 | 61 | |
| 1 | 1.4B USD | 99 | 73 | |
| 1 | 2.1B USD | 99 | 96 | |
| 1 | 885M USD | 99 | 33 | |
| 1 | 15.6B DKK (≈$2.3B) | 99 | 96 | |
| 104 | 787M USD | 73 | 57 | |
| 108 | 3.01T KRW (≈$2.2B) | 72 | 53 | |
| 108 | 8.7B CNY (≈$1.2B) | 72 | 77 | |
| 108 | 118.0B INR (≈$1.4B) | 72 | 68 | |
| 108 | 1.3B USD | 72 | 44 | |
| 112 | 143.1B JPY (≈$973M) | 71 | 75 | |
| 112 | 22.0B SEK (≈$2.2B) | 71 | 51 | |
| 112 | 820M USD | 71 | 41 | |
| 112 | 8.3B SEK (≈$826M) | 71 | 65 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score